Skip to Main Content

Paper Details

Addition of gabapentin to a modified FOLFOX regimen does not reduce oxaliplatin-induced neurotoxicity.
Clin Colorectal Cancer
34
2006
CRC, Gabapentin, PATIENTS, Patients, colorectal cancer, fluorouracil, gabapentin, leucovorin, mFOLFOX, malignancies, metastatic CRC, neurotoxicity, oxaliplatin, patients, sensory neurotoxicity

Datasets

Release 1.2